Literature DB >> 28458252

Acute myeloid leukemia including favorable-risk group samples engraft in NSG mice: just be patient.

Dominique Bonnet1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28458252      PMCID： PMC5477597          DOI： 10.3324/haematol.2017.165159

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.

Authors:  François Vergez; Alexa S Green; Jerome Tamburini; Jean-Emmanuel Sarry; Baptiste Gaillard; Pascale Cornillet-Lefebvre; Melanie Pannetier; Aymeric Neyret; Nicolas Chapuis; Norbert Ifrah; François Dreyfus; Stéphane Manenti; Cecile Demur; Eric Delabesse; Catherine Lacombe; Patrick Mayeux; Didier Bouscary; Christian Recher; Valerie Bardet
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches.

Authors:  Antonella Antonelli; Willy A Noort; Jenny Jaques; Bauke de Boer; Regina de Jong-Korlaar; Annet Z Brouwers-Vos; Linda Lubbers-Aalders; Jeroen F van Velzen; Andries C Bloem; Huipin Yuan; Joost D de Bruijn; Gert J Ossenkoppele; Anton C M Martens; Edo Vellenga; Richard W J Groen; Jan Jacob Schuringa
Journal:  Blood       Date:  2016-10-12       Impact factor: 22.113

3.  Versatile humanized niche model enables study of normal and malignant human hematopoiesis.

Authors:  Ander Abarrategi; Katie Foster; Ashley Hamilton; Syed A Mian; Diana Passaro; John Gribben; Ghulam Mufti; Dominique Bonnet
Journal:  J Clin Invest       Date:  2017-01-09       Impact factor: 14.808

4.  Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.

Authors:  M Feuring-Buske; B Gerhard; J Cashman; R K Humphries; C J Eaves; D E Hogge
Journal:  Leukemia       Date:  2003-04       Impact factor: 11.528

5.  inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice.

Authors:  Jana M Ellegast; Philipp J Rauch; Larisa V Kovtonyuk; Rouven Müller; Ulrich Wagner; Yasuyuki Saito; Nicole Wildner-Verhey van Wijk; Christine Fritz; Anahita Rafiei; Veronika Lysenko; Ewa Dudkiewicz; Alexandre P Theocharides; Davide Soldini; Jeroen S Goede; Richard A Flavell; Markus G Manz
Journal:  Blood       Date:  2016-08-31       Impact factor: 22.113

6.  Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients.

Authors:  Emmanuel Griessinger; Fernando Anjos-Afonso; Jacques Vargaftig; David C Taussig; François Lassailly; Thomas Prebet; Véronique Imbert; Marielle Nebout; Norbert Vey; Christian Chabannon; Andrew Filby; Frederic Bollet-Quivogne; John G Gribben; Jean-François Peyron; Dominique Bonnet
Journal:  Cancer Res       Date:  2016-03-09       Impact factor: 12.701

7.  Stem cell gene expression programs influence clinical outcome in human leukemia.

Authors:  Kolja Eppert; Katsuto Takenaka; Eric R Lechman; Levi Waldron; Björn Nilsson; Peter van Galen; Klaus H Metzeler; Armando Poeppl; Vicki Ling; Joseph Beyene; Angelo J Canty; Jayne S Danska; Stefan K Bohlander; Christian Buske; Mark D Minden; Todd R Golub; Igor Jurisica; Benjamin L Ebert; John E Dick
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

8.  A robust xenotransplantation model for acute myeloid leukemia.

Authors:  P V Sanchez; R L Perry; J E Sarry; A E Perl; K Murphy; C R Swider; A Bagg; J K Choi; J A Biegel; G Danet-Desnoyers; M Carroll
Journal:  Leukemia       Date:  2009-07-23       Impact factor: 11.528

9.  AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

Authors:  Daniel J Pearce; David Taussig; Kazem Zibara; Lan-Lan Smith; Christopher M Ridler; Claude Preudhomme; Bryan D Young; Ama Z Rohatiner; T Andrew Lister; Dominique Bonnet
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

10.  Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.

Authors:  Anna M Paczulla; Stephan Dirnhofer; Martina Konantz; Michael Medinger; Helmut R Salih; Kathrin Rothfelder; Dimitrios A Tsakiris; Jakob R Passweg; Pontus Lundberg; Claudia Lengerke
Journal:  Haematologica       Date:  2017-02-09       Impact factor: 9.941
View more
  2 in total

Review 1.  Tissue engineered models of healthy and malignant human bone marrow.

Authors:  Alan Chramiec; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2019-04-17       Impact factor: 15.470

2.  Engraftment characterization of risk-stratified AML in NSGS mice.

Authors:  Rafael Díaz de la Guardia; Talía Velasco-Hernandez; Francisco Gutiérrez-Agüera; Heleia Roca-Ho; Oscar Molina; Cesar Nombela-Arrieta; Alex Bataller; Jose Luis Fuster; Eduardo Anguita; Susana Vives; Lurdes Zamora; Josep Nomdedeu; María Teresa Gómez-Casares; Manuel Ramírez-Orellana; Helene Lapillonne; Verónica Ramos-Mejia; Juan Carlos Rodríguez-Manzaneque; Clara Bueno; Belen Lopez-Millan; Pablo Menéndez
Journal:  Blood Adv       Date:  2021-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.